INVESTMENT IN UNCONSOLIDATED ENTITIES (Tables)

12 Months Ended

Dec. 31, 2022

Equity Method Investments and Joint Ventures [Abstract]

Schedule of investments in unconsolidated subsidiaries

Below is a summary of our investments in unconsolidated real estate entities as of December 31, 2022 and 2021, respectively (dollars in thousands):

	Ownership (1)		Carrying Amount
	as of December 31,		as of December 31,
	2022	2021	2022		2021
Investment in unconsolidated real estate entities:
Ventas Life Science & Healthcare Real Estate Fund	21.0%	21.1%	$	263,979	$	267,475
Pension Fund Joint Venture	22.9%	22.9%	25,028		29,192
Research & Innovation Development Joint Venture	51.0%	51.0%	284,962		221,363
Ventas Investment Management Platform			573,969		518,030
Atrium Health & Wake Forest Joint Venture	48.5%	—%	5,403		—
All other (2)	34.0%-38.0%	34.0%-50.0%	577		5,435
Total investments in unconsolidated real estate entities			$	579,949	$	523,465

______________________________

(1)     The entities in which we have an ownership interest may have less than a 100% interest in the underlying real estate. The ownership percentages in the table reflect our interest in the underlying real estate. Joint venture members, including us in some instances, have equity participation rights based on the underlying performance of the investments, which could result in non pro rata distributions.

(2)     Includes investments in land parcels, parking structures and other de minimis investments in unconsolidated real estate entities.